FDA review suspends mammograms at Raleigh Radiology office
Posted December 17, 2019 12:40 p.m. EST
Updated December 17, 2019 7:48 p.m. EST
Raleigh, N.C. — Breast imaging services at a Raleigh Radiology office have been suspended after a review of their technical quality.
The review was conducted at the Raleigh office at 3200 Blue Ridge Road by the American College of Radiology and the U.S. Food and Drug Administration.
Dr. Laura Thomas, chair of breast imaging at Raleigh Radiology, released a statement online that the review doesn't mean diagnosis of cancers or diseases were missed in imaging services.
"It's important to note that the review was limited to a small number of mammography cases and only as to the technical quality of the mammography images generated," Thomas said. "The majority of the cases reviewed were acceptable to the ACR, and neither the ACR nor the FDA has indicated that any visible cancer or disease on any image was overlooked."
Raleigh Radiology officials declined to comment Tuesday beyond the online statement.
Patients who received mammograms at the Blue Ridge office between Nov. 7, 2017, and Nov. 6, 2019, will receive letters from Raleigh Radiology and from the FDA. Patients who have questions can call the practice at 919-532-2387.
Raleigh Radiology said the suspension is expected to be temporary, and the office is working with the review agencies to resume mammograms at the Blue Ridge office.
The practice operates six other offices in North Carolina, including Brier Creek, Cary, Clayton, Fuquay-Varina and Wake Forest. Breast imaging services at those locations aren't affected by the review.